Earnings History Data for Abeona Therapeutics (ABEO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Abeona Therapeutics
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | ABEO | Abeona Therapeutics | 264.00 | -0.31 | -0.38 | 0.00 | 5.97 | -0.13 (-2.13%) |
6.10 | 0.0 (0.00%) |
3.05 - 9.01 | 394,005 | 330,000 | 3,093 | |||
|
|
||||||||||||||||||
| 12-08-2024 | PM | ABEO | Abeona Therapeutics | 183.00 | -0.75 | -0.33 | 0.00 | Abeona Therapeutics GAAP EPS of -$0.26 beats by $0.10 [8/12/2024 7:33 AM] |
4.96 | 0.54 (12.22%) |
4.54 | 0.12 (2.71%) |
2.88 - 9.01 | 570,602 | 320,000 | 8,084 | ||
| 15-05-2024 | PM | ABEO | Abeona Therapeutics | 118.00 | -0.53 | -0.47 | 0.00 | Abeona Therapeutics GAAP EPS of -$1.16 misses by $0.65 [5/15/2024 7:54 AM] |
4.70 | 0.50 (11.79%) |
4.31 | 0.11 (2.62%) |
2.83 - 9.01 | 1,002,691 | 1,150,000 | 11,174 | ||
| 18-03-2024 | PM | ABEO | Abeona Therapeutics | 202.00 | -0.64 | -0.51 | 0.00 | Abeona Therapeutics GAAP EPS of -$2.53, revenue of $3.5M [3/18/2024 7:41 AM] |
6.95 | -1.68 (-19.47%) |
8.08 | -0.55 (-6.37%) |
2.24 - 9.01 | 1,334,539 | 390,000 | 31,363 | ||
| 08-08-2023 | PM | ABEO | Abeona Therapeutics | 59.00 | -0.44 | -0.66 | 0.00 | Abeona Therapeutics GAAP EPS of -$0.92 misses by $0.25, revenue of $3.5M [8/8/2023 7:52 AM] |
3.00 | 0.02 (0.67%) |
0.0 | 0.0 (0.00%) |
2.19 - 5.80 | 87,854 | 170,000 | 0 | ||
| 11-05-2023 | PM | ABEO | Abeona Therapeutics | 57.00 | -0.54 | -0.68 | 0.00 | Abeona Therapeutics GAAP EPS of -$0.54 beats by $0.07 [5/11/2023 9:04 AM] |
2.98 | -0.23 (-7.03%) |
3.37 | 0.17 (5.31%) |
2.19 - 6.13 | 160,740 | 90,000 | 2,391 | ||
| 29-03-2023 | ?? | 7:30 AM ET (Mar 29) |
ABEO | Abeona Therapeutics Inc. | 40.02 | N/A | 0.00 | -3.50 | Abeona Therapeutics GAAP EPS of -$5.53 misses by $1.61, revenue of $1.41M misses by $0.91M [3/29/2023 8:10 AM] |
2.82 | 0.01 (0.36%) |
0.0 | 0.0 (0.00%) |
2.19 - 9.35 | 133,183 | 140,000 | 0 | |
| 14-11-2022 | PM | ABEO | Abeona Therapeutics | 25.00 | -1.48 | -1.78 | 0.00 | Abeona Therapeutics GAAP EPS of -$1.48 [11/14/2022 8:45 AM] |
4.16 | -0.23 (-5.35%) |
4.53 | 0.14 (3.19%) |
2.70 - 23.55 | 544,505 | 900,000 | 16,976 | ||
| 11-08-2022 | PM | ABEO | Abeona Therapeutics Inc. | 28.43 | -2.08 | -1.25 | 4.00 | Abeona Therapeutics GAAP EPS of -$2.08, revenue of $1M [8/11/2022 8:41 AM] |
4.69 | 0.53 (12.74%) |
4.08 | -0.08 (-1.92%) |
3.26 - 34.00 | 1,448,055 | 310,000 | 9,932 | ||
| 13-05-2022 | PM | ABEO | Abeona Therapeutics | 20.00 | -0.10 | -0.08 | 0.00 | Abeona Therapeutics GAAP EPS of -$0.14 misses by $0.04, revenue of $0.35M [5/13/2022 7:43 AM] |
0.1577 | 0.0 (0.38%) |
0.15 | -0.01 (-4.52%) |
0.13 - 1.92 | 1,119,128 | 2,890,000 | 39,840 | ||
| 31-03-2022 | PM | ABEO | Abeona Therapeutics Inc. | 42.15 | -0.14 | -0.13 | -0.17 | Abeona Therapeutics GAAP EPS of -$0.45 beats by $0.15, revenue of $3M [3/31/2022 8:02 AM] |
0.3199 | 0.01 (4.34%) |
0.32 | 0.01 (4.04%) |
0.21 - 2.04 | 7,756,468 | 1,320,000 | 2,866 | ||
| 28-07-2021 | AH | After the close (Jul 28) |
ABEO | Abeona Therapeutics Inc. | 131.00 | -0.16 | -0.16 | 0.00 | Abeona Therapeutics EPS beats by $0.01 [7/28/2021 5:36 PM] |
1.24 | -0.04 (-3.44%) |
1.28 | 0.0 (0.00%) |
0.99 - 3.79 | 1,350,695 | 1,990,000 | 27,437 | |
|
||||||||||||||||||
| 18-05-2021 | PM | ABEO | Abeona Therapeutics Inc. | 137.00 | -0.17 | -0.19 | 0.00 | Abeona Therapeutics EPS beats by $0.02 [5/18/2021 7:37 AM] |
1.57 | 0.21 (15.07%) |
1.40 | 0.04 (2.94%) |
0.99 - 3.79 | 1,964,951 | 2,020,000 | 6,999 | ||
| 09-11-2020 | AH | ABEO | Abeona Therapeutics Inc. | 88.17 | -0.08 | -0.13 | -0.35 | Abeona Therapeutics EPS beats by $0.06, beats on revenue [11/9/2020 4:45 PM] |
1.15 | 0.08 (7.48%) |
1.07 | 0.0 (0.00%) |
0.99 - 5.19 | 1,770,164 | 2,063,289 | 5,324 | ||
|
|
||||||||||||||||||